Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,121 public trials 2,033 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Treatment of Patients With Diffuse Large B Cell Lymphoma Who Are Not Suitable for Anthracycline Containing Chemotherapy

NCT01679119

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Stoke Mandeville Hospital (including Wycombe Hospital) Aylesbury, United Kingdom

North Hampshire Hospital Basingstoke, United Kingdom

Royal United Hospital Bath, United Kingdom

Royal Bournemouth Hospital Bournemouth, United Kingdom

View all 40 locations

View Trial Details

Completed

Pulmonary Rehabilitation in Patients With Sarcoidosis

NCT02044939

Conditions: Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +9 more
Locations: Clinique des Maladies Respiratoires, CHRU de LILLE Lille, Nord, France

Service de Pneumologie, CH Béthune Béthune, Pas De Calais, France

Service de Pneumologie, CH Arras Arras, France

Service de pneumologie, Hôpital Avicenne AP-HP Bobigny, France

View Trial Details

Completed

Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT02518555

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study

NCT05972577

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Anemia, +49 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation

NCT01067287

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Rambam Medical Center Haifa, Israel

View Trial Details

Completed

Impact of 2 Resuscitation Sequences on Management of Simulated Pediatric Cardiac Arrest

NCT05474170

Conditions: Cardiopulmonary Arrest, Cardiovascular Diseases, Heart Arrest, +14 more
Locations: Swiss Prehospital Research Day Neuchâtel, Canton of Neuchâtel, Switzerland

View Trial Details

Completed

Vorinostat,Lenalinomide and Dexamethasone in Multiple Myeloma Refractory to Previous Lenalinomide Containing Regimens

NCT01502085

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States

View Trial Details

Completed

A Phase II Study of Carfilzomib in Relapsed Waldenström's Macroglobulinemia (WM) IST-CAR-531

NCT01813227

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States

View Trial Details

Completed

AB-101 as Monotherapy and With Immunotherapy in Patients With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

NCT04673617

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Artiva Clinical Trial Site Birmingham, Alabama, United States

Artiva Clinical Trial Site Tucson, Arizona, United States

Artiva Clinical Trial Site Orange, California, United States

Artiva Clinical Trial Site San Diego, California, United States

View all 21 locations

View Trial Details

Completed

Phase II Protocol for CLL With Fludarabine and Cyclophosphamide With Rituximab (FCR) Plus Lenalidomide

NCT01723839

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
Locations: John Theurer Cancer Center at HackensackUMC Hackensack, New Jersey, United States

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions